Australian Leukemia

The Australasian Leukaemia & Lymphoma Group (ALLG) is a leading not-for-profit collaborative clinical research organization based in Australia and New Zealand. Established in 1973, the group is dedicated to improving the treatment and lives of patients with blood cancers through the design and conduct of independent clinical trials. ALLG's membership includes over 1,000 clinicians and scientists who collaborate on a wide range of studies, including the INTERCEPT and AMLM22-CADENCE trials. The organization maintains the National Blood Cancer Registry and partners with global pharmaceutical companies to evaluate innovative therapies such as menin inhibitors and cell-based immunotherapies.